We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

F:NYSEFord Motor Company Analysis

Data as of 2026-09-02 - not real-time

$13.84

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

At $13.84, Ford Motor Company shows no decisive moving-average alignment, leaving the trend neutral. Over a rolling month the price has lost 3.0%. Momentum indicators put RSI at 45.5 (neutral) with MACD reading bearish. Watch $13.73 as support and $14.55 as the nearer resistance level.
On valuation the read is undervalued — an earnings multiple of 7.2, absent a reliable peer benchmark. Sell-side targets cluster 13.6% above the current quote. Revenue is contracting at 3.8% on a -3.9% profit margin. The 4.30% dividend yield looks stretched against payout coverage.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 31.0%, a beta of 1.16 and a maximum drawdown of 23.4%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.

Top Market Events

Ford beat Q2 estimates and raised guidance, yet shares dropped 9%.Seeking Alpha1monFord: The Valuation Re-Rating Still Has RunwayFord Motor Company remains a buy, supported by raised...Yahoo Finance24dAdvance Auto Parts vs. Ford Motor: Which Automotive Stock Is a Better Buy in 2026?The above button...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading above the 200-day average of 13.48
  • MACD momentum is negative
  • Maximum drawdown of 23.4%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Dividend yield of 4.30% looks stretched against payout coverage
  • Trading above the 200-day average of 13.48
  • Analyst targets imply +13.6% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Dividend yield of 4.30% looks stretched against payout coverage
  • Negative profit margin of -3.9%
  • Analyst targets imply +13.6% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth-3.80%
Profit Margin-3.94%
P/E Ratio7.2
ROE-18.25%
ROA0.35%
Debt/Equity456.71
P/B Ratio1.5
Op. Cash Flow$16.9B
Free Cash Flow$-7940250112

Technical Analysis

TrendNeutral
RSI45.5
Support$13.73
Resistance$14.55
MA 20$14.01
MA 50$14.09
MA 200$13.48
MACDBearish
VolumeIncreasing
Fear & Greed Index92.25

Valuation

Fair Value$2.36
Target Price$15.73
Upside/Downside13.63%
GradeUndervalued
TypeValue
Dividend Yield4.30%

Risk Assessment

Beta1.16
Volatility31.03%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.